Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin
Top Cited Papers
- 20 November 2007
- journal article
- research article
- Published by Elsevier
- Vol. 26 (2) , 201-214
- https://doi.org/10.1016/j.vaccine.2007.10.062
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protectionVaccine, 2006
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Toll-like receptor signallingNature Reviews Immunology, 2004
- A “universal” human influenza A vaccineVirus Research, 2004
- Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2Vaccine, 2003
- Characterization of the 1918 “Spanish” Influenza Virus Matrix Gene SegmentJournal of Virology, 2002
- Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M geneVaccine, 2001
- Immunostimulatory DNA Is a Potent Mucosal AdjuvantCellular Immunology, 1998
- Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits importCell, 1991
- Influenza Virus Uncoating in Infected Cells and Effect of RimantadineJournal of General Virology, 1982